Identification of an intronic enhancer regulating RANKL expression in osteocytic cells.
Minglu YanMasayuki TsukasakiRyunosuke MuroYutaro AndoKazutaka NakamuraNoriko KomatsuTakeshi NittaTadashi OkamuraKazuo OkamotoHiroshi TakayanagiPublished in: Bone research (2023)
The bony skeleton is continuously renewed throughout adult life by the bone remodeling process, in which old or damaged bone is removed by osteoclasts via largely unknown mechanisms. Osteocytes regulate bone remodeling by producing the osteoclast differentiation factor RANKL (encoded by the TNFSF11 gene). However, the precise mechanisms underlying RANKL expression in osteocytes are still elusive. Here, we explored the epigenomic landscape of osteocytic cells and identified a hitherto-undescribed osteocytic cell-specific intronic enhancer in the TNFSF11 gene locus. Bioinformatics analyses showed that transcription factors involved in cell death and senescence act on this intronic enhancer region. Single-cell transcriptomic data analysis demonstrated that cell death signaling increased RANKL expression in osteocytic cells. Genetic deletion of the intronic enhancer led to a high-bone-mass phenotype with decreased levels of RANKL in osteocytic cells and osteoclastogenesis in the adult stage, while RANKL expression was not affected in osteoblasts or lymphocytes. These data suggest that osteocytes may utilize a specialized regulatory element to facilitate osteoclast formation at the bone surface to be resorbed by linking signals from cellular senescence/death and RANKL expression.
Keyphrases
- bone loss
- cell cycle arrest
- cell death
- induced apoptosis
- poor prognosis
- binding protein
- single cell
- transcription factor
- bone mineral density
- data analysis
- nuclear factor
- rna seq
- copy number
- oxidative stress
- long non coding rna
- genome wide
- endothelial cells
- pi k akt
- body composition
- palliative care
- postmenopausal women
- cell proliferation
- young adults
- cell therapy
- big data
- bone regeneration
- lps induced